Avanos Medical AVNS PM&R — Depreciation and amortization expense

Similar metrics at other companies

TEXMP — Depreciation, depletion and amortization

$5M0.0%

MTRNPerformance Materials — Depreciation, depletion, and amortization

$11.02M+16.8%

ENOVPrevention & Recovery — Depreciation

$5.07M+21.5%

WFRDPRI — D&A

$24M+33.3%

LAZAsset Management — Depreciation and amortization of property (included in adjusted non-compensation expense)

$1.45M+5.0%

NGVTPerformance Materials — Total depreciation and amortization

$10.9M+10.1%

Questions, answered.

What is Avanos Medical's PM&R — depreciation and amortization expense?

Avanos Medical (AVNS) reported PM&R — depreciation and amortization expense of -$3.7M in Q1 2026.

How has Avanos Medical's PM&R — depreciation and amortization expense changed year-over-year?

Avanos Medical's PM&R — depreciation and amortization expense increased by 5.1% year-over-year, from -$3.9M to -$3.7M.

What is the long-term trend for Avanos Medical's PM&R — depreciation and amortization expense?

Over 2 years (2023 to 2025), Avanos Medical's PM&R — depreciation and amortization expense has grown at a 5.1% compound annual growth rate (CAGR), from -$13.3M to -$14.7M.

What does PM&R — depreciation and amortization expense mean?

Represents the non-cash allocation of the cost of tangible and intangible assets used by the Pain Management and Recovery segment over their useful lives. This metric is vital for understanding the capital intensity and asset base maintenance requirements of the business unit.